Archive: 2025/11

DOAC Dosing in Obesity: What Works, What Doesn’t, and What to Watch For

DOACs like apixaban and rivaroxaban are safe and effective for obese patients at standard doses. Dabigatran increases GI bleeding risk. Avoid dose escalation. Edoxaban needs caution in extreme obesity.